The groundbreaking rise of Viagra has long been a example of pharmaceutical success, however its legacy within the broader sector now presents questions about potential returns . Generic versions are undercutting patent protection , leading to worries that investing in companies heavily reliant to Viagra's once-dominant influence could be a specula